Latest Massachusetts News | Page 2

Linguistic luminary, Sir Patu Hohepa’s legacy
NSF funds internet-connected ocean observatory through 2028
Cornell to lead carbon-cutting effort in aluminum recycling
Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer
Tuning the Chern Number in the Nitrogen-Vacancy Center in Diamond
A tax on menthol cigarettes would work better than statewide bans, UW study finds
Update on US regulatory review of Ultomiris in NMOSD
AI systems have learned how to deceive humans. What does that mean for our future?
Strong in Shanghai Ranking
Soliris approved in Japan for paediatric patients with generalised myasthenia gravis (gMG)
Police Involvement May Hamstring Overdose Outreach Efforts
Using broad race categories in medicine hides true health risks
Mosquitoes: Fact and Fiction on Bite Prevention
Carbon dioxide – not water – triggers explosive volcanoes
Unveiling the Anomalous Dynamics of Non-collinear Antiferromagnets
Delivering world-leading mathematics in South Australian public schools
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
Soliris approved in the EU for children and adolescents with refractory generalised myasthenia gravis (gMG)
TRISH selects 2023 class of space health postdoctoral fellows
Space-ready menstrual cup giant leap for womankind
UNSW Sydney rockets into the global top 20 in latest QS Rankings
Researchers make a quantum computing leap with a magnetic twist
Do Children Inherit Parents’ Stressful Experiences?
IATA Launches World Sustainability Symposium
Soliris recommended for approval in the EU by CHMP for children and adolescents with refractory generalised myasthenia gravis (gMG)
MIT’s global innovation initiative hones in on WA
Wildfire smoke downwind affects health, wealth and mortality
Award-winning therapy brings light into darkness
Hungry gold miners created Victoria’s Murray cod fisheries – and we’re still dealing with the consequences
Emerging field of circadian medicine gets a boost with new global association
Soliris approved in China for treatment of adults with refractory generalised myasthenia gravis
Greening Shipping Industry
Lingering effects of Neanderthal DNA found in modern humans
Tufts Clinical and Translational Science Institute Receives $78.4 Million NIH Grant
Cyber War is here. Are we prepared?
Swarming microrobots self-organize into diverse patterns
Premier Announces 30th Governor Of Victoria
Ultomiris approved in Japan for the prevention of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD)
Academy welcomes 20 new Fellows for their outstanding contributions to science
Kreps: Generative AI holds promise, peril for democracies
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Cornell economist co-edits PNAS issue focused on value of clean water
The AGA Research Foundation awards $2.66 million in research funding
NEURO-TTRansform Phase III results presented at AAN showed eplontersen demonstrated consistent and sustained improvement in all measures of disease and quality of…
Securing a Sustainable Energy Future Demands Corporate Leadership: Three Ways to Act Now
TRISH seeking proposals for data transfer technology for space health
DMI Allows Magnon-Magnon Coupling in Hybrid Perovskites